NEW YORK (GenomeWeb) – Investment bank Evercore ISI has downgraded Becton Dickinson's stock to Hold from Buy based on the company's recent outperformance of the market.

Over the past two years, BD has "massively outperformed" the S&P 500 Index, wrote Evercore analyst Vijay Kumar in his note today. Evercore's elevation of Becton to a Buy in June 2013 was based on the idea that the stock was underappreciated.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In a statement, National Institutes of Health Director Francis Collins says sexual harassment is "morally indefensible" and "unacceptable."

Octopuses might owe their intelligence to their liberal alterations to their genes, Cosmos reports.

Stat News and ProPublica report that African Americans are underrepresented in cancer clinical trials.

In Cell this week: genomic analysis of abdominal aortic aneurysm, effect of probiotics on the microbiome, and more.